Global Electroanatomical Mapping Market – Industry Trends and Forecast to 2030

 Electroanatomical Mapping Market Analysis and Size

The abundance of evidence of atrial fibrillation and the consequent increase in the abundance of ablation methods to accelerate exchange germination is a significant determinant supporting the extension of the aforementioned exchange. Some factors, such as adverse healthcare reforms and a scarcity of proficient and qualified electrophysiologists, may restrain market growth. To overcome certain challenges, technological advancements and developing syndicates will provide opportunities for market growth.

Data Bridge Market Research analyses that the electroanatomical mapping market which was USD 1.8 billion in 2022, is expected to reach USD 3.59 billion by 2030, at a CAGR of 9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Electroanatomical Mapping Market Scope and Segmentation  

Market Definition

Electroanatomical mapping practises account for the majority of contact mapping operations revenue. The abundance of evidence of atrial fibrillation and the consequent increase in the abundance of ablation methods to accelerate exchange germination is a significant determinant supporting the extension of the aforementioned exchange.

Electroanatomical Mapping Market Dynamics

Drivers

• Rise in the cardiac mapping

The rise in the use of contact cardiac mapping in recent years can be attributed to the benefits offered by contact cardiac mapping, such as their accuracy in locating and detecting the exact locations of mapping and ablation catheters in a 3D environment, their efficiency in imaging along with multi-electrode basket catheter by recording in just a few beats, and their ability to detect arrhythmic locations. Furthermore, accuracy and efficiency in measuring and detecting images, as well as increased chances of disease diagnosis and ablation, are driving the market.

• Increase in the number of heart problems

The increase in the number of heart problems such as (cardiac arrest), arrhythmia cases and their prevalence, technological advancements; and the use of modern-day scientific approaches such as advanced imaging techniques, software, and the use of artificial intelligence and machine learning approaches are major factors driving the electroanatomical mapping market.

Opportunities

• Rising prevalence of cardiac-related issues

The prevalence of cardiac-related issues such as arrhythmia, cardiac arrest, valve blocks, and heart attack is currently on the rise. Surgery is a common treatment method for cardiac arrest and heart failure, which can result in irregular heartbeats at times or over time. This medical condition is known as arrhythmia, and it can occur after or before a cardiac operation. Cardiac mapping is an important treatment method for arrhythmia. It is an effective method of treatment. The areas of cardiac muscles where there is an irregular heartbeat are identified and removed during cardiac mapping. These are the certain factors which are expected to grow the market.

Restraints/Challenges

• Scarcity of proficient and qualified electrophysiologists

Some factors, such as adverse healthcare reforms and a scarcity of proficient and qualified electrophysiologists act as a restraint on market growth.

This electroanatomical mapping market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the electroanatomical mapping market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Electroanatomical Mapping Market Scope

The electroanatomical mapping market is segmented on the basis of indication and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

• Atrial Fibrillation
• Atrial Flutter
• AVNRT
• Other Arrhythmias

 End Use

• Hospitals
• Diagnostic Centers
• Clinics
• Others

Electroanatomical Mapping Market Regional Analysis/Insights

The electroanatomical mapping market is analyzed and market size insights and trends are provided by country, indication and end use as referenced above.

The countries covered in the electroanatomical mapping market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the electroanatomical mapping market due to the large occurrence of cardiac patients, medical devices advancements and good foundation base of healthcare infrastructure.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the growing incidence of cancer such as bladder, esophagus, liver, pancreas, and others, high presence of major manufacturers across the U.S. Furthermore, technological advancements and rising foreign investment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The electroanatomical mapping market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for electroanatomical mapping market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the electroanatomical mapping market. The data is available for historic period 2011-2021.

Competitive Landscape and Electroanatomical Mapping Market Share Analysis

The electroanatomical mapping market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to electroanatomical mapping market.

Some of the major players operating in the electroanatomical mapping market are:

• Medtronic (Ireland)
• Biosense Webster (U.S.)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• EP Solutions (Switzerland)
• Koninklijke Philips N.V. (Netherlands)
• CoreMap Inc. (U.S.)
• BIOTRONIK SE & Co KG (Germany)
• Epmap-System (Germany)

SKU-59349